Stockreport

Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Palatin Technologies, Inc.  (PTN) 
NASDAQ:AMEX Investor Relations: palatin.com/investors/overview
PDF 11 min read In This Article PTN Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock co [Read more]